We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – Products

resDetect™ Manufacturing Process Residue Detection Solutions
Product
Advertisement

Emphasizing Bio-Pharmaceutical CMC Residue Quality Control

resDetect™ is a series of reagent kits designed to follow international legal and regulatory requirements and guidelines for the detection of residual components in the biopharmaceutical manufacturing process.
An illustration of a conveyor belt in a factory, with multiple vaccine vials being filled systematically
Whitepaper

How To Accelerate Vaccine Production – And Avoid Speed Bumps

This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.
Three men cutting a rope.
Product News

Single Use Support Opens US Office

Fluid and cold chain management expert Single Use Support has opened a subsidiary in Lexington, Massachusetts. Equipped with a product showroom, the office will also serve as a base for increased US staff.
An organoid.
Product News

Products and Services for Diversifying Preclinical Models

AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.
Quantoom laboratory.
Product News

Gates Foundation To Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally

At the 2023 Grand Challenges Annual Meeting, Bill Gates, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries.
A close up of someone holding a glass test tube.
Product News

Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies

Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.
mRNA-Based Therapies
Compendium

mRNA Ready To Make Its Mark: Developing the mRNA Therapeutics of the Future

It was the mRNA vaccine that led the charge against SARS-CoV-2 in the recent pandemic, but now researchers are asking: what other therapeutic applications could benefit from mRNA technology?
Identifying Monoclonal Antibodies
App Note / Case Study

Discover the Latest in Protein Sequencing Technology

This application note demonstrates the successful identification of two low-abundance monoclonal antibodies using next-generation protein sequencing.
Pyrophosphatase and T7 RNA Polymerase packets.
Product News

Launch of High-Quality Enzymes Suitable for Pre-Clinical and Process Development in mRNA Vaccine

Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.
Vaccine Development
Product
Advertisement

Influenza Vaccine Development and Production Solutions

Learn more about influenza vaccine solutions!
Advertisement